Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selection of high-risk patients for device intervention with the new advances in technology.

Journal of electrocardiology - 1 Jan 2000

Moss Arthur J

Abstract excerpt

The recent clinical therapeutic studies involving high-risk cardiac patients with genetic or acquired heart disease provide valuable insights into the potential for new advances in the technology for improving risk stratification to identify patients who can benefit from device therapy.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Evidence-Based Medicine
Share to Genetic Predisposition to Disease
Share to Heart Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patient Selection

Share to Prevalence

Share to Prognosis

Share to Risk Assessment

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 22999323
DOI: 10.1016/j.jelectrocard.2012.08.004
PMCID: PMC3505600

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selection of high-risk patients for device intervention with the new advances in technology.PMID 22999323Read ↗

Phenotype-guided approach for device-based therapies in heart failure.Semantic proximity Read ↗

Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden deathSemantic proximity Read ↗

Targeting device therapy: genomics of sudden death.Semantic proximity Read ↗

Device Interventions for Heart Failure.Semantic proximity Read ↗

The American Heart Association's New Institute for Precision Cardiovascular Medicine.Semantic proximity Read ↗

Gene Therapy for Cardiovascular Disease: Basic Research and Clinical ProspectsSemantic proximity Read ↗

The Extravascular Implantable Cardioverter-Defibrillator: The Pivotal Study PlanSemantic proximity Read ↗

Future Physicians in the Era of Precision Cardiovascular Medicine.Semantic proximity Read ↗

Addressing the complexity of cardiovascular disease by design.Semantic proximity Read ↗

The merits of the ICD for inherited heart rhythm disorders: A critical re-appraisal.Semantic proximity Read ↗

Innovations of Diagnosis and Treatment of Coronary Artery DiseaseSemantic proximity Read ↗

PROSE – Prospective Randomized Trial of the On-X Mechanical Prosthesis and the St Jude Medical Mechanical Prosthesis Evaluation (EDIT – March 21,2021& April 16,2021)Part 1 – Preoperative Demographics and Preoperative and Operative Risk FactorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.